Stocks and Investing Stocks and Investing
Mon, March 8, 2021
Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021
Tue, March 2, 2021

Vikram Purohit Maintained (AXSM) at Buy with Increased Target to $104 on, Mar 2nd, 2021


Published on 2024-10-27 15:49:02 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $101 to $104 on, Mar 2nd, 2021.

Vikram has made no other calls on AXSM in the last 4 months.



There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $129 on, Friday, January 8th, 2021
  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $120 on, Wednesday, December 16th, 2020